Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Absolutely Natural
WARNING LETTER
•Absolutely Natural•April 24, 2025

Absolutely Natural – FDA Warning Letter, Apr 24, 2025

Record Details

The FDA issued a Warning Letter to Absolutely Natural following an inspection of its Melbourne facility from April 22 to 24, 2025. The agency identified significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals, leading to the classification of the company"s over-the-counter drug products as adulterated.

Key issues included a failure to thoroughly investigate unexplained discrepancies and out-of-specification (OOS) results. Specifically, the company did not adequately investigate a July 2024 batch failure caused by microbiological contamination, including Pseudomonas aeruginosa, lacking a proper root cause analysis and failing to assess other potentially affected batches. The FDA found the company"s initial response insufficient, noting a lack of detail regarding affected products and a retrospective OOS review.

Furthermore, Absolutely Natural failed to adequately validate its alternative rapid microbiological test methods, such as the (b)(4) system, used for finished drug products. These methods lacked proper quantification, identification of objectionable microorganisms, and failed to demonstrate sufficient capability for detecting Burkholderia cepacia complex. Validation studies also deviated from compendial methods without scientific justification, and the company did not verify the manufacturer"s validation.

To address these issues, the FDA requires Absolutely Natural to conduct a retrospective, independent review of all invalidated OOS results, comprehensively remediate its OOS investigation and CAPA programs, and provide a detailed action plan to improve its overall investigation system. The company must also establish and document the accuracy and suitability of its test methods through proper validation.

Company
Absolutely Natural
Inspection date
April 24, 2025
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Daniel Richards
  • Francis Godwin (Director)
View Company Profile

ID · 2fd2a80a-462e-4ecb-b86c-abd378c48103

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 211FD&C Act 501(a)(2)(B)21 CFR 211.19221 CFR 211.165(e)21 CFR 211.84(d)(1)21 CFR 211.34FD&C Act 201(i)21 U.S.C. 321(i)

Full citation text and observation details available on the Dashboard.

Other documents for Absolutely Natural
  • 483 - 2025-04-24April 24, 2025
  • 483 - 2019-06-14June 14, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Absolutely Natural
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.